BridgeBio Oncology Therapeutics, In (BBOT) PT Lowered to $25 at JPMorgan
Tweet
Share
E-mailGet Alerts BBOT Hot Sheet
Price: $8.82 +0.23%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
JPMorgan analyst Priyanka Grover lowered the price target on BridgeBio Oncology Therapeutics, In (NASDAQ: BBOT) to $25.00 (from $27.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Science Applications (SAIC) PT Raised to $123 at UBS
- Ultrapar Participacoes SA (UGPA3:BZ) (UGP) PT Raised to BRL39 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
